Baotou Dongbao Bio-Tech Co.,Ltd

300239

CNE100001583

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-06-02 pm EDT			5-day change	1st Jan Change
4.94 ^CNY	-2.76%		-3.70%	-20.71%

May. 24	Baotou Dongbao Bio-Tech Co.,Ltd Announces 2023 Final Cash Distribution Plan on A Shares, Payable on 31 May 2024	CI
May. 15	Baotou Dongbao Bio-Tech Co.,Ltd Approves Management Appointments	CI

Baotou Dongbao Bio-Tech Co Ltd Appoints Zhao Xiumei as Chief Financial Officer of the Company

May 15, 2017 at 06:30 am EDT

Baotou Dongbao Bio-Tech Co Ltd. has announced that it has appointed Zhao Xiumei as Chief Financial Officer of the company.

Latest news about Baotou Dongbao Bio-Tech Co.,Ltd

Baotou Dongbao Bio-Tech Co.,Ltd Announces 2023 Final Cash Distribution Plan on A Shares, Payable on 31 May 2024	May. 24	CI
Baotou Dongbao Bio-Tech Co.,Ltd Approves Management Appointments	May. 15	CI
Baotou Dongbao Bio-Tech Co.,Ltd Approves Final Cash Dividend for the Year 2023	May. 15	CI
Baotou Dongbao Bio-Tech Co.,Ltd Proposes Final Cash for the Year 2023	Apr. 23	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Baotou Dongbao Bio-Tech Raises 455 Million Yuan From Bond Sale	23-08-04	MT
Baotou Dongbao Bio-Tech Co.,Ltd Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 19 May 2023	23-05-11	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Baotou Dongbao Bio-Tech Co.,Ltd Approves Cash Dividend for the Year 2022	23-04-17	CI
Baotou Dongbao Bio-Tech Co.,Ltd Proposes Cash Dividend for 2022	23-03-21	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Qingdao Yiqing Biotechnology Co., Ltd. announced that it has received CNY 100.45 million in funding from Baotou Dongbao Bio-Tech Co.,Ltd, Qingdao Gon Technology Co., Ltd., Qingdao Deyu Biological Investment Partnership (limited partnership)	22-10-12	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Qingdao Yiqing Biotechnology Co., Ltd. announced that it expects to receive CNY 100.45 million in funding from Baotou Dongbao Bio-Tech Co.,Ltd, Qingdao Gon Technology Co., Ltd., Qingdao Deyu Biological Investment Partnership (limited partnership)	22-08-24	CI
Baotou Dongbao Bio-Tech Co.,Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 10 June 2022	22-06-02	CI
Baotou Dongbao Bio-Tech Co.,Ltd Approves Profit Distribution Plan for 2021	22-05-19	CI
Baotou Dongbao Bio-Tech Co.,Ltd Proposes Cash Dividend for 2021	22-04-26	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-23	CI
Baotou Dongbao Bio-Tech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Baotou Dongbao Bio-Tech Co.,Ltd Approves Executive Appointments	21-09-13	CI

Chart Baotou Dongbao Bio-Tech Co.,Ltd

Duration

Period

More charts

Baotou Dongbao Bio-Tech Co., Ltd is principally engaged in the research, development, manufacture and distribution of gelatin series products and low molecular mass collagen. The Company primarily provides gelatin, which is used in the manufacture of empty capsules and food additives; calcium hydrophosphate, which is used in feed additives, as well as collagen series products, which are used in foods, cosmetics, health care products. The Company distributes its products in both domestic and overseas markets, with domestic markets as its major markets.

Sector

Pharmaceuticals

Calendar

2024-08-20 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BAOTOU DONGBAO BIO-TECH CO.,LTD	-20.71%	405M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+13.53%	41.95B
OTSUKA HOLDINGS CO., LTD.	+22.20%	22.53B
SANDOZ GROUP AG	+15.11%	14.91B
CIPLA LIMITED	+17.35%	14.11B
ZYDUS LIFESCIENCES LIMITED	+45.62%	12.5B
ONO PHARMACEUTICAL CO., LTD.	-9.44%	6.75B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.55%	5.6B